These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978 [TBL] [Abstract][Full Text] [Related]
6. Characterization of immunoreactivity with whole-slide imaging and digital analysis in high-grade serous ovarian cancer. Jäntti T; Luhtala S; Mäenpää J; Staff S Tumour Biol; 2020 Nov; 42(11):1010428320971404. PubMed ID: 33169632 [TBL] [Abstract][Full Text] [Related]
7. Immunotyping in tubo-ovarian high-grade serous carcinoma by PD-L1 and CD8+ T-lymphocytes predicts disease-free survival. Bansal A; Srinivasan R; Rohilla M; Rai B; Rajwanshi A; Suri V; Chandra Saha S APMIS; 2021 May; 129(5):254-264. PubMed ID: 33455015 [TBL] [Abstract][Full Text] [Related]
8. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer. Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206 [TBL] [Abstract][Full Text] [Related]
9. The roles of T-lymphocyte subpopulations (CD4 and CD8), intercellular adhesion molecule-1 (ICAM-1), HLA-DR receptor, and mast cells in etiopathogenesis of pterygium. Beden U; Irkeç M; Orhan D; Orhan M Ocul Immunol Inflamm; 2003 Jun; 11(2):115-22. PubMed ID: 14533030 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray. Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656 [TBL] [Abstract][Full Text] [Related]
11. Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response. Yang H; Gu X; Fan R; Zhu Q; Zhong S; Wan X; Chen Q; Zhu L; Feng F J Ovarian Res; 2023 Nov; 16(1):223. PubMed ID: 37993916 [TBL] [Abstract][Full Text] [Related]
12. Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation. Pinte S; Caetano B; Le Bras A; Havet C; Villain G; Dernayka R; Duez C; Mattot V; Soncin F J Biol Chem; 2016 Nov; 291(46):24017-24028. PubMed ID: 27650497 [TBL] [Abstract][Full Text] [Related]
13. Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer. Pinto MP; Balmaceda C; Bravo ML; Kato S; Villarroel A; Owen GI; Roa JC; Cuello MA; Ibañez C Gynecol Oncol; 2018 Oct; 151(1):10-17. PubMed ID: 30078505 [TBL] [Abstract][Full Text] [Related]
14. High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer. Oh J; Park SH; Lee TS; Oh HK; Choi JH; Choi YS J Gynecol Oncol; 2014 Oct; 25(4):334-41. PubMed ID: 25142627 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumor PD-L1 expression combined with CD8 Wang Q; Lou W; Di W; Wu X Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888 [TBL] [Abstract][Full Text] [Related]
16. Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro. Rudolph H; Klopstein A; Gruber I; Blatti C; Lyck R; Engelhardt B Eur J Immunol; 2016 Sep; 46(9):2187-203. PubMed ID: 27338806 [TBL] [Abstract][Full Text] [Related]
17. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer. Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243 [TBL] [Abstract][Full Text] [Related]
18. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Callahan MJ; Nagymanyoki Z; Bonome T; Johnson ME; Litkouhi B; Sullivan EH; Hirsch MS; Matulonis UA; Liu J; Birrer MJ; Berkowitz RS; Mok SC Clin Cancer Res; 2008 Dec; 14(23):7667-73. PubMed ID: 19047092 [TBL] [Abstract][Full Text] [Related]
19. Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes. Stumpf M; Hasenburg A; Riener MO; Jütting U; Wang C; Shen Y; Orlowska-Volk M; Fisch P; Wang Z; Gitsch G; Werner M; Lassmann S Br J Cancer; 2009 Nov; 101(9):1513-21. PubMed ID: 19861998 [TBL] [Abstract][Full Text] [Related]
20. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related] [Next] [New Search]